Valeant Pharmaceuticals International, Inc.
MarketLine (a Datamonitor Company)
22 Jan 2014
Available for Immediate Download
Valeant Pharmaceuticals International, Inc. Company Profile is the essential source for top-level company data and information. Valeant Pharmaceuticals International, Inc. Company Profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy. Valeant Pharmaceuticals International (Valeant) operates as a multinational specialty pharmaceutical company. It develops, manufactures and markets pharmaceutical products and medical devices. The company operates in Americas, Europe, Asia, Middle East and Africa. It is headquartered in Quebec, Canada and employs around 7,000 people. The company recorded revenues of $3,546.6 million in the fiscal year ended December 2012, an increase of 44% over 2011. The company's operating profit was $79.7 million in fiscal 2012, a decrease of 73.4% compared to 2011. Its net loss was $116 million in fiscal 2012, as compared to the net profit of $159.6 million in 2011. Scope of the Report - Provides all the crucial information on Valeant Pharmaceuticals International, Inc. required for business and competitor intelligence needs -Data is supplemented with details on Valeant Pharmaceuticals International, Inc. history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available statement from Valeant Pharmaceuticals International, Inc. Reasons to Purchase - Support sales activities by understanding your customers’ businesses better - Understand prospective partners and suppliers - Keep fully up to date on your competitors’ business structure, strategy and prospects - Obtain the most up to date company information available